184 related articles for article (PubMed ID: 23129491)
1. Meningitis outbreak shines light on compounding pharmacies.
Shaughnessy AF
BMJ; 2012 Nov; 345():e7432. PubMed ID: 23129491
[No Abstract] [Full Text] [Related]
2. Compounding interest: a tragedy caused by contaminated steroids turned the spotlight on compounding pharmacies.
Hinkley KN
State Legis; 2013 Jun; 39(6):22-3. PubMed ID: 23805443
[No Abstract] [Full Text] [Related]
3. How gaps in regulation of compounding pharmacy set the stage for a multistate fungal meningitis outbreak.
Teshome BF; Reveles KR; Lee GC; Ryan L; Frei CR
J Am Pharm Assoc (2003); 2014; 54(4):441-5. PubMed ID: 25063265
[TBL] [Abstract][Full Text] [Related]
4. Causes and root causes of a multistate fungal meningitis outbreak.
Lipowski EE; Smith WT; Navarro RP
J Am Pharm Assoc (2003); 2015; 55(2):118. PubMed ID: 25616150
[No Abstract] [Full Text] [Related]
5. Compounding pharmacies: before and after an inspection.
Kulkarni D; Ricketts S
Int J Pharm Compd; 2013; 17(5):358-62. PubMed ID: 24459779
[TBL] [Abstract][Full Text] [Related]
6. 2013 State Compounding Legislation Tracker.
Miller DG
Int J Pharm Compd; 2013; 17(5):375-8. PubMed ID: 24459782
[No Abstract] [Full Text] [Related]
7. Compounding pharmacies: a viable option, or merely a liability?
O'Brien D; Cohen I; Kennedy DJ
PM R; 2013 Nov; 5(11):974-81. PubMed ID: 24247017
[No Abstract] [Full Text] [Related]
8. The "Lists": What Do They Mean?
Voliva J
Int J Pharm Compd; 2016; 20(6):477-479. PubMed ID: 28339386
[No Abstract] [Full Text] [Related]
9. GMPs vs GCPs: manufacturing and compounding definitions.
Allen LV
Int J Pharm Compd; 2013; 17(5):356. PubMed ID: 24459778
[No Abstract] [Full Text] [Related]
10. Introduction to Quality Control in a Compounding Pharmacy.
Allen LV
Int J Pharm Compd; 2016; 20(6):481-484. PubMed ID: 28339387
[TBL] [Abstract][Full Text] [Related]
11. The U.S. Food and Drug Administration responds to the International Academy of Compounding Pharmacists' outsourcing letter.
Int J Pharm Compd; 2014; 18(3):208. PubMed ID: 25306767
[No Abstract] [Full Text] [Related]
12. Description of outbreaks of health-care-associated infections related to compounding pharmacies, 2000-12.
Staes C; Jacobs J; Mayer J; Allen J
Am J Health Syst Pharm; 2013 Aug; 70(15):1301-12. PubMed ID: 23867487
[TBL] [Abstract][Full Text] [Related]
13. U.S. Food and Drug Administration List of Drugs NOT to be Used in Compounded Medications for Humans (The Negative List).
Int J Pharm Compd; 2016; 20(6):457-458. PubMed ID: 28339383
[No Abstract] [Full Text] [Related]
14. Analytic Methods Used in Quality Control in a Compounding Pharmacy.
Allen LV
Int J Pharm Compd; 2017; 21(1):31-37. PubMed ID: 28346196
[TBL] [Abstract][Full Text] [Related]
15. Compounding USP <797>: inspection, regulation, and oversight of sterile compounding pharmacies.
Kastango ES
JPEN J Parenter Enteral Nutr; 2012 Mar; 36(2 Suppl):38S-39S. PubMed ID: 22275322
[TBL] [Abstract][Full Text] [Related]
16. Bipartisan effort. Dems, GOP call for investigation into outbreak.
Zigmon J
Mod Healthc; 2012 Oct; 42(42):7, 16. PubMed ID: 23163083
[No Abstract] [Full Text] [Related]
17. [Quality control in the pharmacy].
Cohen EH
Pharm Weekbl; 1968 Apr; 103(17):472-85. PubMed ID: 5665059
[No Abstract] [Full Text] [Related]
18. Compounding pharmacies: who is in charge?
Pergolizzi JV; Labhsetwar S; LeQuang JA
Pain Pract; 2013 Mar; 13(3):253-7. PubMed ID: 23350709
[TBL] [Abstract][Full Text] [Related]
19. What gastroenterologists should know about the gray market, herbal remedies, and compounded pharmaceuticals and their regulation by the Food and Drug Administration.
Ehrenpreis ED; Kulkarni P; Burke C;
Am J Gastroenterol; 2013 May; 108(5):642-6. PubMed ID: 23644956
[No Abstract] [Full Text] [Related]
20. Improving and enforcing compounding pharmacy practices to protect patients.
Pegues DA
Clin Infect Dis; 2006 Oct; 43(7):838-40. PubMed ID: 16941363
[No Abstract] [Full Text] [Related]
[Next] [New Search]
